End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
46,300 KRW | +4.75% | +26.16% | +27.55% |
2023 | Cosmecca Korea Co., Ltd.(KOSDAQ:A241710) added to S&P Global BMI Index | CI |
2023 | Cosmecca Korea Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- With regards to fundamentals, the enterprise value to sales ratio is at 913.83 for the current period. Therefore, the company is undervalued.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Personal Products
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+27.55% | 361M | - | ||
+0.62% | 261B | B- | ||
+19.02% | 20.69B | B+ | ||
0.00% | 18.4B | - | - | |
+8.84% | 11.56B | A- | ||
-10.06% | 9.69B | A- | ||
+17.79% | 7.66B | B+ | ||
+14.08% | 6.19B | B | ||
+2.13% | 4.62B | B+ | ||
-15.27% | 3.91B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- A241710 Stock
- Ratings Cosmecca Korea Co., Ltd.